Clascoterone as a Novel Treatment for Androgenetic Alopecia

    May 2020 in “ Clinical and Experimental Dermatology ”
    H. Sun, Deshan F. Sebaratnam
    Studysummary This correspondence discusses clascoterone as a potential new treatment for androgenetic alopecia but reports no clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. A Summary of In Vitro, Phase I, and Phase II Studies Evaluating the Mechanism of Action, Safety, and Efficacy of Clascoterone (Cortexolone 17a Propionate, CB-03-01) in Androgenetic Alopecia Journal of The American Academy of Dermatology · 2019
    2. Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia Archives of Dermatology · 2010